Polar Capital Biotechnology
The active funds beating the MSCI World for the past decade
The best-performing Elite Rated funds in 2025
Upside vs. Downside: how to judge if a fund really outperforms
The stock market wisdom of Roger Federer
ISA season 2025 deadline: Last-minute picks for your portfolio
Meet the funds making money in each of the past 10 years
Four ways to invest in a growing population
Investing through a winter of discontent
Summer 2020: the funds gaining and losing their Elite Ratings